1-3 of 3
Keigo Sano
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Identification of a Patients-Derived CD34+ Myeloma Cell Population with Tumor-Propagating Capacity and Resistance to Anticancer Drugs

Free
Kentaro Serizawa, Hirokazu Tanaka, MD PhD, Ayano Fukui, MD, Ryosuke Fujiwara, MD, Keigo Sano, MD, Hiroaki Inoue, MD, Takahiro Kumode, MD, Yasuhiro Taniguchi, MD, Yasuyoshi Morita, MD, Luis Espinoza, MDPhD, Itaru Matsumura, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1774.
https://doi.org/10.1182/blood.V130.Suppl_1.1774.1774
Published: 2017
Journal Articles

Reduced-Dosage Of Three Drugs Combination Of Cyclophosphamide, Bortezomib and Dexamethasone (reduced-CyBorD) Is Suitable For Elderly Frail Patients With Multiple Myeloma

Free
Hideo Yagi, MD, PhD, Ryosuke Fujiwara, M.D., Keigo Sano, M.D., Keiko Yamazaki, M.D., Hitoshi Hanamoto, M.D., Ph.D., Kazuo Tsubaki, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1963.
https://doi.org/10.1182/blood.V122.21.1963.1963
Published: 2013
Journal Articles

Reduced-Dosage of Three Drugs Combination of Cyclophosphamide, Bortezomib and Dexamethasone (reduced-CyBorD) Retains High Response Rate with Less Toxicities in Elderly Patients with Multiple Myeloma

Free
Hideo Yagi, MD, PhD, Ryosuke Fujiwara, M.D., Keigo Sano, M.D., Fujita Mariko, M.D., Takashi Iizuka, M.D., Keiko Yamazaki, M.D., Hitoshi Hanamoto, M.D., Ph.D., Kazuo Tubaki, M.D., Ph.D.
Journal: Blood
Blood (2012) 120 (21): 1865.
https://doi.org/10.1182/blood.V120.21.1865.1865
Published: 2012